Xiangyu Medical Co Stock Fundamentals

688626 Stock   31.72  0.23  0.73%   
Xiangyu Medical Co fundamentals help investors to digest information that contributes to Xiangyu Medical's financial success or failures. It also enables traders to predict the movement of Xiangyu Stock. The fundamental analysis module provides a way to measure Xiangyu Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xiangyu Medical stock.
The current year's Interest Expense is expected to grow to about 2.9 M, whereas Tax Provision is forecasted to decline to about 15 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Xiangyu Medical Co Company Current Valuation Analysis

Xiangyu Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Xiangyu Medical Current Valuation

    
  4.68 B  
Most of Xiangyu Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xiangyu Medical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Xiangyu Medical Co has a Current Valuation of 4.68 B. This is 67.43% lower than that of the Health Care Equipment & Supplies sector and 62.34% lower than that of the Health Care industry. The current valuation for all China stocks is 71.86% higher than that of the company.

Xiangyu Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Xiangyu Medical's current stock value. Our valuation model uses many indicators to compare Xiangyu Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xiangyu Medical competition to find correlations between indicators driving Xiangyu Medical's intrinsic value. More Info.
Xiangyu Medical Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.35  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Xiangyu Medical Co is roughly  2.84 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Xiangyu Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Xiangyu Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Xiangyu Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xiangyu Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xiangyu Medical could also be used in its relative valuation, which is a method of valuing Xiangyu Medical by comparing valuation metrics of similar companies.
Xiangyu Medical is currently under evaluation in current valuation category among its peers.

Xiangyu Fundamentals

About Xiangyu Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Xiangyu Medical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xiangyu Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xiangyu Medical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue744.8 M589.5 M
Cost Of Revenue233.7 M191 M

Currently Active Assets on Macroaxis

Other Information on Investing in Xiangyu Stock

Xiangyu Medical financial ratios help investors to determine whether Xiangyu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xiangyu with respect to the benefits of owning Xiangyu Medical security.